View ValuationNovoray 향후 성장Future 기준 점검 5/6Novoray은 연간 수입과 매출이 각각 38.3%와 28.6% 증가할 것으로 예상되고 EPS는 연간 38.1%만큼 증가할 것으로 예상됩니다.핵심 정보38.3%이익 성장률38.07%EPS 성장률Chemicals 이익 성장29.3%매출 성장률28.6%향후 자기자본이익률n/a애널리스트 커버리지Low마지막 업데이트23 Apr 2026최근 향후 성장 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • Jun 30Novoray Corporation to Report First Half, 2026 Results on Aug 15, 2026Novoray Corporation announced that they will report first half, 2026 results on Aug 15, 2026Declared Dividend • Jun 06Dividend of CN¥0.50 announcedShareholders will receive a dividend of CN¥0.50. Ex-date: 10th June 2026 Payment date: 10th June 2026 Dividend yield will be 0.3%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (40% earnings payout ratio) but not adequately covered by cash flows (91% cash payout ratio). The dividend has increased by an average of 19% per year over the past 6 years and payments have been stable during that time. EPS is expected to grow by 38% over the next year, which should provide support to the dividend and adequate earnings cover.Board Change • May 20Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Fan Wu was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.공시 • Apr 22Novoray Corporation, Annual General Meeting, May 18, 2026Novoray Corporation, Annual General Meeting, May 18, 2026, at 14:00 China Standard Time. Location: 2F, Comprehensive Building, No. 6, Zhujiang Road, Xinpu Economic Development Zone, Haizhou District, Lianyungang, Jiangsu China공시 • Mar 30Novoray Corporation to Report Q1, 2026 Results on Apr 28, 2026Novoray Corporation announced that they will report Q1, 2026 results on Apr 28, 2026공시 • Dec 26Novoray Corporation to Report Fiscal Year 2025 Results on Apr 22, 2026Novoray Corporation announced that they will report fiscal year 2025 results on Apr 22, 2026공시 • Sep 30Novoray Corporation to Report Q3, 2025 Results on Oct 30, 2025Novoray Corporation announced that they will report Q3, 2025 results on Oct 30, 2025공시 • Jun 30Novoray Corporation to Report First Half, 2025 Results on Aug 27, 2025Novoray Corporation announced that they will report first half, 2025 results on Aug 27, 2025공시 • Mar 28Novoray Corporation to Report Q1, 2025 Results on Apr 29, 2025Novoray Corporation announced that they will report Q1, 2025 results on Apr 29, 2025공시 • Mar 26Novoray Corporation, Annual General Meeting, Apr 17, 2025Novoray Corporation, Annual General Meeting, Apr 17, 2025, at 14:00 China Standard Time. Location: 3F, Comprehensive Building, No. 6, Zhujiang Road, Xinpu Economic Development Zone, Haizhou District, Lianyungang, Jiangsu China공시 • Dec 27Novoray Corporation to Report Fiscal Year 2024 Results on Mar 26, 2025Novoray Corporation announced that they will report fiscal year 2024 results on Mar 26, 2025Valuation Update With 7 Day Price Move • Nov 08Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥57.50, the stock trades at a forward P/E ratio of 35x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 23% over the past year.Reported Earnings • Oct 31Third quarter 2024 earnings released: EPS: CN¥0.37 (vs CN¥0.28 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.37 (up from CN¥0.28 in 3Q 2023). Revenue: CN¥250.4m (up 27% from 3Q 2023). Net income: CN¥67.4m (up 30% from 3Q 2023). Profit margin: 27% (in line with 3Q 2023). Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China.공시 • Sep 30Novoray Corporation to Report Q3, 2024 Results on Oct 31, 2024Novoray Corporation announced that they will report Q3, 2024 results on Oct 31, 2024Valuation Update With 7 Day Price Move • Sep 28Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥44.57, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 4.8% over the past year.Reported Earnings • Aug 26Second quarter 2024 earnings released: EPS: CN¥0.35 (vs CN¥0.23 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.35 (up from CN¥0.23 in 2Q 2023). Revenue: CN¥241.1m (up 43% from 2Q 2023). Net income: CN¥65.8m (up 49% from 2Q 2023). Profit margin: 27% (up from 26% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 24% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China.공시 • Jun 28Novoray Corporation to Report First Half, 2024 Results on Aug 26, 2024Novoray Corporation announced that they will report first half, 2024 results on Aug 26, 2024Reported Earnings • Apr 26First quarter 2024 earnings released: EPS: CN¥0.28 (vs CN¥0.15 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.28 (up from CN¥0.15 in 1Q 2023). Revenue: CN¥202.3m (up 40% from 1Q 2023). Net income: CN¥51.7m (up 80% from 1Q 2023). Profit margin: 26% (up from 20% in 1Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China.공시 • Mar 29Novoray Corporation to Report Q1, 2024 Results on Apr 26, 2024Novoray Corporation announced that they will report Q1, 2024 results on Apr 26, 2024공시 • Mar 26Novoray Corporation, Annual General Meeting, Apr 19, 2024Novoray Corporation, Annual General Meeting, Apr 19, 2024, at 13:30 China Standard Time. Location: The Company's Meeting Room, Lianyungang, Jiangsu ChinaReported Earnings • Mar 26Full year 2023 earnings released: EPS: CN¥0.94 (vs CN¥1.01 in FY 2022)Full year 2023 results: EPS: CN¥0.94 (down from CN¥1.01 in FY 2022). Revenue: CN¥711.7m (up 7.5% from FY 2022). Net income: CN¥174.0m (down 7.6% from FY 2022). Profit margin: 24% (down from 28% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 24% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China.Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥35.60, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 13x in the Chemicals industry in China.Valuation Update With 7 Day Price Move • Nov 15Investor sentiment improves as stock rises 23%After last week's 23% share price gain to CN¥57.99, the stock trades at a forward P/E ratio of 41x. Average forward P/E is 16x in the Chemicals industry in China.Reported Earnings • Oct 26Third quarter 2023 earnings released: EPS: CN¥0.28 (vs CN¥0.21 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.28 (up from CN¥0.21 in 3Q 2022). Revenue: CN¥196.7m (up 43% from 3Q 2022). Net income: CN¥51.8m (up 33% from 3Q 2022). Profit margin: 26% (down from 28% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China.Reported Earnings • Aug 19Second quarter 2023 earnings released: EPS: CN¥0.23 (vs CN¥0.26 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.23 (down from CN¥0.26 in 2Q 2022). Revenue: CN¥169.1m (down 2.4% from 2Q 2022). Net income: CN¥44.3m (down 11% from 2Q 2022). Profit margin: 26% (down from 29% in 2Q 2022). Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China.Buying Opportunity • Aug 11Now 21% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be CN¥53.21, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 25% over the last 3 years. Earnings per share has grown by 24%. Revenue is forecast to grow by 76% in 2 years. Earnings is forecast to grow by 94% in the next 2 years.Valuation Update With 7 Day Price Move • Jul 12Investor sentiment improves as stock rises 15%After last week's 15% share price gain to CN¥51.75, the stock trades at a forward P/E ratio of 36x. Average forward P/E is 16x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥44.12 per share.Reported Earnings • May 02First quarter 2023 earnings released: EPS: CN¥0.23 (vs CN¥0.34 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.23 (down from CN¥0.34 in 1Q 2022). Revenue: CN¥145.0m (down 18% from 1Q 2022). Net income: CN¥28.7m (down 33% from 1Q 2022). Profit margin: 20% (down from 24% in 1Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China.Valuation Update With 7 Day Price Move • Apr 06Investor sentiment improves as stock rises 32%After last week's 32% share price gain to CN¥87.58, the stock trades at a forward P/E ratio of 43x. Average forward P/E is 16x in the Chemicals industry in China.Board Change • Mar 15Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Dong Hui Pan was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.이익 및 매출 성장 예측XSSC:688300 - 애널리스트 향후 추정치 및 과거 재무 데이터 (CNY Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/20271,960602N/A565112/31/20261,568439N/A38713/31/20261,171301133233N/A12/31/20251,116293157255N/A9/30/20251,090287167263N/A6/30/20251,036273103200N/A3/31/2025997263191291N/A12/31/2024960251165255N/A9/30/2024895234167248N/A6/30/2024841218164236N/A3/31/2024769197137189N/A12/31/2023712174194247N/A9/30/2023685182139203N/A6/30/2023625169156248N/A3/31/2023630174130277N/A12/31/202266218886241N/A9/30/202265717524213N/A6/30/2022686186-47161N/A3/31/2022663179-64117N/A12/31/2021625173-55153N/A9/30/2021581169-94117N/A6/30/2021522147-42135N/A3/31/2021473130-57104N/A12/31/2020404111-3490N/A9/30/2020367921998N/A6/30/2020341822995N/A3/31/20203217827100N/A12/31/201931575N/A81N/A9/30/201929869N/A97N/A6/30/201929267N/A70N/A3/31/201927760N/A53N/A12/31/201827858N/A56N/A9/30/201826454N/A34N/A6/30/201824950N/A12N/A3/31/201823046N/A9N/A12/31/201721142N/A6N/A9/30/201719341N/A17N/A6/30/201717639N/A27N/A3/31/201716536N/A22N/A12/31/201615433N/A18N/A9/30/201614327N/AN/AN/A6/30/201613220N/A16N/A3/31/201612719N/A12N/A12/31/201512218N/A7N/A9/30/201512119N/A3N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: 688300 의 연간 예상 수익 증가율(38.3%)이 saving rate(2.4%)보다 높습니다.수익 vs 시장: 688300 의 연간 수익(38.3%)이 CN 시장(27.5%)보다 빠르게 성장할 것으로 예상됩니다.고성장 수익: 688300 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.수익 대 시장: 688300 의 수익(연간 28.6%)이 CN 시장(연간 16.8%)보다 빠르게 성장할 것으로 예상됩니다.고성장 매출: 688300 의 수익(연간 28.6%)은 연간 20%보다 빠르게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: 688300의 자본 수익률이 3년 후 높을 것으로 예상되는지 판단하기에 데이터가 부족합니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/07/09 20:11종가2026/07/09 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Novoray Corporation는 2명의 분석가가 다루고 있습니다. 이 중 1명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Yilin HouChina International Capital Corporation LimitedWei LiuHaitong International Research Limited
공시 • Jun 30Novoray Corporation to Report First Half, 2026 Results on Aug 15, 2026Novoray Corporation announced that they will report first half, 2026 results on Aug 15, 2026
Declared Dividend • Jun 06Dividend of CN¥0.50 announcedShareholders will receive a dividend of CN¥0.50. Ex-date: 10th June 2026 Payment date: 10th June 2026 Dividend yield will be 0.3%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (40% earnings payout ratio) but not adequately covered by cash flows (91% cash payout ratio). The dividend has increased by an average of 19% per year over the past 6 years and payments have been stable during that time. EPS is expected to grow by 38% over the next year, which should provide support to the dividend and adequate earnings cover.
Board Change • May 20Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Fan Wu was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • Apr 22Novoray Corporation, Annual General Meeting, May 18, 2026Novoray Corporation, Annual General Meeting, May 18, 2026, at 14:00 China Standard Time. Location: 2F, Comprehensive Building, No. 6, Zhujiang Road, Xinpu Economic Development Zone, Haizhou District, Lianyungang, Jiangsu China
공시 • Mar 30Novoray Corporation to Report Q1, 2026 Results on Apr 28, 2026Novoray Corporation announced that they will report Q1, 2026 results on Apr 28, 2026
공시 • Dec 26Novoray Corporation to Report Fiscal Year 2025 Results on Apr 22, 2026Novoray Corporation announced that they will report fiscal year 2025 results on Apr 22, 2026
공시 • Sep 30Novoray Corporation to Report Q3, 2025 Results on Oct 30, 2025Novoray Corporation announced that they will report Q3, 2025 results on Oct 30, 2025
공시 • Jun 30Novoray Corporation to Report First Half, 2025 Results on Aug 27, 2025Novoray Corporation announced that they will report first half, 2025 results on Aug 27, 2025
공시 • Mar 28Novoray Corporation to Report Q1, 2025 Results on Apr 29, 2025Novoray Corporation announced that they will report Q1, 2025 results on Apr 29, 2025
공시 • Mar 26Novoray Corporation, Annual General Meeting, Apr 17, 2025Novoray Corporation, Annual General Meeting, Apr 17, 2025, at 14:00 China Standard Time. Location: 3F, Comprehensive Building, No. 6, Zhujiang Road, Xinpu Economic Development Zone, Haizhou District, Lianyungang, Jiangsu China
공시 • Dec 27Novoray Corporation to Report Fiscal Year 2024 Results on Mar 26, 2025Novoray Corporation announced that they will report fiscal year 2024 results on Mar 26, 2025
Valuation Update With 7 Day Price Move • Nov 08Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥57.50, the stock trades at a forward P/E ratio of 35x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 23% over the past year.
Reported Earnings • Oct 31Third quarter 2024 earnings released: EPS: CN¥0.37 (vs CN¥0.28 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.37 (up from CN¥0.28 in 3Q 2023). Revenue: CN¥250.4m (up 27% from 3Q 2023). Net income: CN¥67.4m (up 30% from 3Q 2023). Profit margin: 27% (in line with 3Q 2023). Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China.
공시 • Sep 30Novoray Corporation to Report Q3, 2024 Results on Oct 31, 2024Novoray Corporation announced that they will report Q3, 2024 results on Oct 31, 2024
Valuation Update With 7 Day Price Move • Sep 28Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥44.57, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 4.8% over the past year.
Reported Earnings • Aug 26Second quarter 2024 earnings released: EPS: CN¥0.35 (vs CN¥0.23 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.35 (up from CN¥0.23 in 2Q 2023). Revenue: CN¥241.1m (up 43% from 2Q 2023). Net income: CN¥65.8m (up 49% from 2Q 2023). Profit margin: 27% (up from 26% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 24% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China.
공시 • Jun 28Novoray Corporation to Report First Half, 2024 Results on Aug 26, 2024Novoray Corporation announced that they will report first half, 2024 results on Aug 26, 2024
Reported Earnings • Apr 26First quarter 2024 earnings released: EPS: CN¥0.28 (vs CN¥0.15 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.28 (up from CN¥0.15 in 1Q 2023). Revenue: CN¥202.3m (up 40% from 1Q 2023). Net income: CN¥51.7m (up 80% from 1Q 2023). Profit margin: 26% (up from 20% in 1Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China.
공시 • Mar 29Novoray Corporation to Report Q1, 2024 Results on Apr 26, 2024Novoray Corporation announced that they will report Q1, 2024 results on Apr 26, 2024
공시 • Mar 26Novoray Corporation, Annual General Meeting, Apr 19, 2024Novoray Corporation, Annual General Meeting, Apr 19, 2024, at 13:30 China Standard Time. Location: The Company's Meeting Room, Lianyungang, Jiangsu China
Reported Earnings • Mar 26Full year 2023 earnings released: EPS: CN¥0.94 (vs CN¥1.01 in FY 2022)Full year 2023 results: EPS: CN¥0.94 (down from CN¥1.01 in FY 2022). Revenue: CN¥711.7m (up 7.5% from FY 2022). Net income: CN¥174.0m (down 7.6% from FY 2022). Profit margin: 24% (down from 28% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 24% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China.
Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥35.60, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 13x in the Chemicals industry in China.
Valuation Update With 7 Day Price Move • Nov 15Investor sentiment improves as stock rises 23%After last week's 23% share price gain to CN¥57.99, the stock trades at a forward P/E ratio of 41x. Average forward P/E is 16x in the Chemicals industry in China.
Reported Earnings • Oct 26Third quarter 2023 earnings released: EPS: CN¥0.28 (vs CN¥0.21 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.28 (up from CN¥0.21 in 3Q 2022). Revenue: CN¥196.7m (up 43% from 3Q 2022). Net income: CN¥51.8m (up 33% from 3Q 2022). Profit margin: 26% (down from 28% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China.
Reported Earnings • Aug 19Second quarter 2023 earnings released: EPS: CN¥0.23 (vs CN¥0.26 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.23 (down from CN¥0.26 in 2Q 2022). Revenue: CN¥169.1m (down 2.4% from 2Q 2022). Net income: CN¥44.3m (down 11% from 2Q 2022). Profit margin: 26% (down from 29% in 2Q 2022). Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China.
Buying Opportunity • Aug 11Now 21% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be CN¥53.21, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 25% over the last 3 years. Earnings per share has grown by 24%. Revenue is forecast to grow by 76% in 2 years. Earnings is forecast to grow by 94% in the next 2 years.
Valuation Update With 7 Day Price Move • Jul 12Investor sentiment improves as stock rises 15%After last week's 15% share price gain to CN¥51.75, the stock trades at a forward P/E ratio of 36x. Average forward P/E is 16x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥44.12 per share.
Reported Earnings • May 02First quarter 2023 earnings released: EPS: CN¥0.23 (vs CN¥0.34 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.23 (down from CN¥0.34 in 1Q 2022). Revenue: CN¥145.0m (down 18% from 1Q 2022). Net income: CN¥28.7m (down 33% from 1Q 2022). Profit margin: 20% (down from 24% in 1Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China.
Valuation Update With 7 Day Price Move • Apr 06Investor sentiment improves as stock rises 32%After last week's 32% share price gain to CN¥87.58, the stock trades at a forward P/E ratio of 43x. Average forward P/E is 16x in the Chemicals industry in China.
Board Change • Mar 15Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Dong Hui Pan was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.